throbber
Journal of Critical Carc 2005 20 35
`
`45
`
`ELSEVIER
`
`Journal of
`
`Critical Care
`
`and prophytaxis of stress ulcer in
`PathophysioLogy
`intensive care unit patients
`
`Neil StoLLman MDa1 David
`
`Metz MD
`
`Division of Gastroenterology Department of Medicine University of Ca4fornia San Francisco
`CA 94110 USA
`bDivisiofl of Gastroenterology Department of Medicine
`PA 19104 USA
`
`University of Pennsylvania Health System Philadelphia
`
`San Francisco
`
`Received 12 May 2004 revised 24 August 2004 accepted
`
`12 October 2004
`
`Abstract Gastrointestinal
`Of
`
`frequently occur in patients admitted to the intensive care unit
`complications
`disease SRMD can lengthen
`and bleeding related to stress-related mucosal
`these ulceration
`hospitalization and increase mortality The purpose of this review is to discuss the many risk factors and
`of SRMD and
`illnesses that have
`evaluate
`the evidence
`role in the pathophysiology
`underlying
`pertaining to SRMD prophylaxis
`in the intensive care unit population
`Suppressing acid production is
`stress-related mucosal ulceration and clinically important
`fundamental
`to preventing
`gastrointestinal
`bleeding Traditional prophylactic options for SRMD in critically ill patients include antacids sucralfate
`antagonists H2RAs and proton pump inhibitors Many
`clinicians
`histamine2-receptor
`prescribe
`infusions of H2RAs for stress ulcer prophylaxis
`intermittent
`practice that has not been approved for
`this indication and may not provide the necessary degree or duration of acid suppression required to
`related bleeding New data suggest
`that proton pump inhibitors
`stress ulcer
`suppress acid
`prevent
`production more completely in critically
`ill patients but more studies are required to assess their clinical
`The prophylactic
`this indication
`to prevent stress ulcer
`regimen chosen
`and safety for
`the risk factors and underlying disease state of individual patients to
`bleeding should take into account
`therapy to those most likely to benefit
`
`effectiveness
`
`provide the best
`
`2005 Elsevier
`
`Inc All rights reserved
`
`Keywords
`
`Pathuphysiulogy
`
`Prophylaxis
`
`Ulcer
`
`Introduction
`
`An estimated
`are admitted
`4.4 million patients
`intensive care units ICUs each year Of
`12
`or 500000 patients die in the ICU
`Gastrointestinal
`GI complications eg gastric and intestinal motor dys
`
`these about
`
`to
`
`author
`Fact Ray Center
`for Digestive
`Correcponrliog
`Oaklaod CA 94609 USA Tel
`510 444 3297 fax
`510 444 6421
`mail address ostotlmanmcdsfgh.ucsfcdu
`
`Stollrnao
`
`t-teatih
`
`0883 9441
`
`sec
`
`froot matter
`
`2005 Elscvicr
`
`Inc All
`
`rights reserved
`
`doil0 1016 j.jcrc.2004.t0.003
`
`function as well as stress-related mucosal disease
`
`in these patients and adversely affect patient
`frequently occur
`outcomes Gastrointestinal motor dysfttnction may predis
`to impaired enteral nutrition and pulmonary
`pose patients
`Stress-related mucosal
`aspiration of gastric contents
`
`occurs in many criti
`damage
`an acute erosive gastritis
`cally ill patients in ICUs and may develop within 24 hours of
`important GI
`admission
`The incidence
`of clinically
`bleeding defined as overt bleeding complicated by hemo
`dynamic instability decrease in hemoglobin and/or need for
`
`METZ-6
`
`5/8/15
`
`Denise Bach RPR
`
`
`
`Page 1 of 11
`
`Patent Owner Ex. 2012
`Lupin v. Pozen
`IPR2015-01774
`
`

`
`36
`
`Stotiman D.C Metz
`
`1.500 in
`
`blood transfusion from SRMD in the ICU population was
`In addition
`prospective study of 2252 patients
`the morbidity associated with this type of severe ulceration
`and bleeding can increase the length of stay in the ICU by up
`days and mortality is as much as 4-fold higher than it
`to
`in ICU patients without
`this complication
`
`is
`
`PathophysioLogy and pathogenesis of SRMD
`
`Several
`
`factors have
`
`contents
`
`of SRMD
`role in the pathogenesis
`including gastric acid secretion mucosal ischemia as result
`of splanchnic hypoperfusion and reflux of upper intestinal
`into the stomach Fig
`Gastric hypoperftt
`to an imbalance between
`oxygen supply and
`sion leads
`demand that may induce mucosal damage Moreover
`reperfusion after prolonged hypoperfusion may itself
`result
`in nonocclusive mesenteric ischemia and mucosal damage
`As
`reduced ability to
`result of ischemia there is also
`neutralize hydrogen ions which can contribute to cell death
`such as mucous produc
`and ulceration Protective processes
`tion may also be impaired further promoting SRMD
`In
`showed
`animal studies Ritchie
`that elevated gastric acid
`levels bile salts and ischemia must all be present
`lesions to form whereas
`none of these factors alone or in
`combination with each other led to ulceration
`In stress ulceration homeostasis of the gastric mucosa is
`defense mechanisms
`
`for gastric
`
`disrupted
`
`as are
`
`the
`
`cellular
`
`that
`
`mucosal cells on contact
`
`Thus prevention of acid injury
`and stress ulceration might be achieved
`by therapies that
`reduce acid secretion or enhance protective mechanisms
`signs of SRMD include multiple sub
`The endoscopic
`epithelial petechiae progressing to superficial erosions and
`in some cases discrete ulceration particularly
`fundus
`these lesions are characterized
`Microscopically
`
`in the gastric
`
`loss of
`by focal
`the superficial epithelium coagulation
`necrosis of the mucosa and hemorrhage
`do not usually perforate and tend to bleed from superficial
`Because of the diffused nature of
`mucosal capillaries
`
`These lesions
`
`the lesions
`
`stress ulcers are not generally amenable
`
`to
`
`endoscopic
`
`therapy
`
`2.1 SpLanchnic hypoperfusion
`
`Critical
`
`trauma
`
`severe
`
`splanchnic
`
`illness that warrants admission to an ICU eg
`shock bums sepsis
`can
`hypoperfision which has
`of SRMD Significant
`pathogenesis
`even when
`blood flow can
`occur
`
`contribute to
`
`major
`
`role in the
`
`decreases
`
`in visceral
`
`systemic circulation is
`
`maintained and conventional measures of systemic tissue
`regional GI oxy
`oxygenation may not accurately
`Intramucosal pH which can be measured
`genation
`of
`marker of the adequacy
`using gastric tonometry
`oxygenation in the upper GI
`and
`is used in
`experimental settings to assess the magnitude of splanchnic
`ischemia
`
`reflect
`
`tract
`
`is
`
`Cellular defense
`
`highly acidic gastric milieu
`normally protect against
`is primarily mediated by gastric prosta
`been shown to
`glandins which in animal models have
`prevent ulcer formation and accelerate
`the healing process
`This seems to occur partly because prostaglandins reduce
`acid secretion More importantly they have been shown to
`
`exert
`
`direct cytoprotective effect
`
`against agents that kill
`
`2.2 UnderLying iLLness
`
`Critical
`
`illness is often characterized by hypotcnsion and
`hypovolemia which can directly
`
`contribute
`
`to gastric
`
`hypoperfusion
`
`In addition critically
`
`ill
`
`patients often
`
`exhibit
`
`inflammatory responses
`cytokines that can also result in hypoperfusion
`
`involving
`
`the release of
`
`lncreaaed
`catecholamines
`
`Increased vasoconstriction
`
`Critical
`
`Illness
`
`Hypovolemia
`
`Cardiac output ___________
`
`Proinflammatory
`releaae
`
`Splanchnic hypopeusion_cokcne
`
`Reduced
`HCO3
`secretion
`
`Reduced
`mucosal
`
`ood flow
`
`Decreased
`
`GI motility
`
`Acid back
`diffusion
`
`Fig
`
`Pathophysiology of stress ulcers Adapted from Chest 2001 Hasp Pract 1980
`
`Acute stress ulcer
`
`
`
`Page 2 of 11
`
`Patent Owner Ex. 2012
`Lupin v. Pozen
`IPR2015-01774
`
`

`
`Stress uLcer prophyLaxis
`
`2.3 MechanicaL ventiLation
`
`strategies
`
`Mechanical ventilation can influence systemic hemody
`namics especially with potentially injurious ventilator
`such as high tidal volumes or high positive end
`expiratory pressure PEEP High PEEP decreases
`venous
`return and reduces preload which in tum may reduce cardiac
`output CO
`and result
`in splanchnic
`hypoperfusion
`PEEP promotes
`plasma-renin-angiotensin-aldosterone
`activity as well as catecholaminc release which may also
`contribute to splanchnic hypoperflision
`Mesenteric blood flow and CO were found to signifi
`decrease with increasing levels of PEEP in rats
`cantly
`An inverse relationship
`randomized to PEEP vs control
`between
`and
`plasma catecholamine
`increasing
`in CO was observed
`decreases
`in dogs treated
`doses of PEEP
`Effects on the sympathetic nervous
`system have also been validated in human beings In
`study
`of 10 healthy males receiving continuous positive-pressure
`breathing muscle
`nerve activity rapidly
`sympathetic
`increased as did measurements of vasoprcssin
`and plasma
`
`levels
`
`ith graded
`
`as compared to control
`In addition
`renin activity
`mechanical ventilation with large tidal volumes and high
`been shown in animals to
`have
`end-expiratory pressures
`promote release ofpulinonaiy cytokines which can enter
`from the lungs potentially
`
`the
`
`causing
`
`systemic circulation
`
`splanchnic hypoperftrsion
`Despite these data showing that PEEP can negatively
`influence blood flow the effect of PEEP on UI bleeding in
`the ICU selling remains unknown
`
`2.4 Medications used in the 1W
`
`deleterious effects
`
`Medications administered to patients in the ICU can have
`especially when com
`on GI
`function
`pounded with the effects of mechanical ventilation Opiates
`can decrease gut
`and sedatives such as benzodiazepines
`Other agents
`include vasopressors
`
`motility arid impair venous
`return
`may contribute to UI complications
`and antibiotics
`Theoretically
`any drug resulting in
`hypotension decreased heart rate or CO can in turn reduce
`mescnteric blood flow and put
`critically ill patient at risk
`of developing SRMD
`
`that
`
`2.4.1 Helicobacter pylon
`Helicobacter pylon has been implicated as the causative
`of chronic gastritis and peptic
`in the pathogenesis
`Its relationship to stress ulceration and GI bleeding
`is not well documented The relatively few studies
`however
`
`agent
`
`ulcer
`
`exploring
`
`severity
`
`this association yielded conflicting
`survey of critically ill patients
`prospective epidemiologic
`an ICU found
`significantly higher rate of seropositivity for
`in the ICU gmoop than in the control groop 67% vs
`Hpyloni
`39% .001
`The relationship between Hpyloni status
`and UI bleeding was not significant but
`toward increasing seropositivity with increasing bleeding
`from 5000 scropositivity
`among patients with
`
`results
`
`in
`
`there was
`
`trend
`
`occult bleeding to 100% seropositivity
`
`among those with
`prospective cohort
`significant bleeding
`ICU
`patients admitted to the
`
`clinically
`
`analysis
`
`50 consecutive
`
`In
`
`37
`
`requiring mechanical ventilation were screened for Hpyloni
`infection using the laser-assisted ratio analyzer urea breath
`injury Of
`to assess mucosal
`test and underwent cndoscopy
`the 29 patients who developed minor mucosal disease
`34.5% were infected with Hpyloni On the contrary of the
`15 patients that presented with major mucosal disease 80%
`were
`infected
`the severity of
`supporting the theory that
`injury is correlated with
`Yamamoto et al
`inoculated
`
`mucosal
`
`pylon infection
`group of test animals
`with Hpyloni After these control animals were subjected
`to
`fonnation
`
`stress
`
`ulcer
`
`and bleeding occurred
`treatment
`regardless of whether the animals were or were not
`pylon However after
`minutes of treatment
`bleeding rate and index were significantly
`.036 and
`infected group than in the uninfected group
`respectively The ulcer index was also higher
`.03
`the infected group It was determined that Hpyloni
`infection
`lowers the threshold for gastric mucosal
`injuries in the early
`phase of stress exposure but suppresses
`mucosal
`lesions in the late phase
`In contrast another study found no association between
`and UI bleeding This
`study was
`
`with
`
`pylon
`
`infection
`
`infected
`
`the
`
`higher
`
`in the
`
`in
`
`the formation of
`
`conducted
`in patients with and
`prospectively over
`year
`without evidence of UI bleeding admitted to the ICU after
`received
`
`cardiac
`
`stress ulcer prophy
`
`surgery All patients
`laxis with ranitidine Results showed
`that Hpyloni
`was not significantly more prevalent
`in patients with upper
`UI bleeding than in those without bleeding
`Only
`limited association was found in another study Among 874
`critically ill patients admitted to an ICU and followed for
`weeks 76 8.7o developed
`Anti
`stress gastritis
`was found to be an independent
`pylon immunoglobulin
`for stress gastritis but not anti
`
`risk factor
`
`infection
`
`pylon
`
`subset
`
`possibly suggesting that only
`immunoglobulin
`of individuals with chronic Hpyloni
`
`infection is at risk for
`
`stress gastritis
`
`CompLications associated with SRMD
`
`Mortality rates increase proportionately with the inci
`dence and severity of SRMD In
`prospective multicenter
`studies Cook ct al
`found significant differences in
`important UI bleeding and
`mortality between
`clinically
`In these studies patients who
`nonbleeding patients Fig
`result of SRMD had mortality rates of 490o and
`bled as
`46
`In contrast mortality rates for nonbleeding patients
`were 9% and 210o
`.001 and
`.0001 respectively
`These findings are consistent with those of
`study
`that evaluated
`of cimetidine in prevention
`and treatment of stress-induced UI
`lesions In this study
`correlated with severity of UI
`mortality was significantly
`injury mortality rates were 57o in patients with
`
`the effectiveness
`
`mucosal
`
`
`
`Page 3 of 11
`
`Patent Owner Ex. 2012
`Lupin v. Pozen
`IPR2015-01774
`
`

`
`38
`
`50
`
`45
`
`40
`
`35
`
`25
`20
`
`15
`
`10
`
`Bleeding
`
`Non bleeding
`
`Patients
`
`Fig
`
`Differences in mortality between bleeding
`2219 patients Asterisk
`nnnbleeding
`Adapted from Engi
`
`Med 1994
`
`indicates
`
`33 and
`.001
`
`.03
`who are at
`
`endoscopically evident ulcers and/or bleeding and 24 in
`patients with nonhemorrhagic erosions or normal mucosa
`Because it
`
`is possible to identify patients
`
`should
`risk for bleeding strategies
`the greatest
`on the prevention of SRMD and bleeding
`logically focus
`rather than on its treatment after the fact Such an approach
`associated with SRMD and
`
`may minimize complications
`ideally improve outcomes
`
`3.1 Impact of GI bLeeding
`
`on EU patients
`
`Clinically important GI bleeding may cause hemody
`namic instability or require red blood cell transflisions The
`risks of transfusion include infection and potential
`
`attendant
`
`for
`
`immunosuppression
`
`incompatibilities
`fnr an increased
`
`as well as possible blood-related
`As noted earlier there is
`potential
`length nf stay in the IClI among patients
`with significant bleeding compared to nonbleeders as well
`increase in mortality
`
`as
`
`statistically significant
`
`Risk factors for stress
`
`uLcerreLated bLeeding
`
`As noted critically
`
`ill patients admitted to ICUs are at
`stress ulceration
`and
`
`as
`
`and
`
`it
`
`is
`
`subsequent
`risk for developing
`result of both underlying disease
`bleeding
`therapeutic interventions Prophylaxis against
`stress ulcers
`can significantly minimize bleeding but such therapy may
`adverse
`be costly and can have
`effects Therefore
`to identify risk factors that would substantiate
`
`important
`and target
`need for prophylaxis
`to those
`study involving more that 2200 patients
`highest
`risk
`admitted to ICUs primarily postcardiovascular
`evaluated
`risk factors for stress ulcer
`therapy was withheld
`
`potential
`
`bleeding
`
`Prophylactic
`
`interventions
`
`at
`
`surgery
`
`related
`
`in all
`
`the
`
`StoLtman D.C Metz
`
`except 674 patients these patients had received
`drugs that
`history of peptic ulcer
`increased their risk of bleeding had
`or gastritis were undergoing high-risk surgery or required
`prophylaxis for other reasons eg head injury trauma
`The only independent
`important
`for clinically
`study were
`stress ulcer bleeding
`by the
`respiratory failure requiring more than 48 hours of
`mechanical ventilation odds ratio 15.6 and coagulopathy
`Among 847 patients who had ooe or
`odds ratio
`both of these risk factors 313.7
`developed
`clinically
`important bleeding whereas among 1405 patients who had
`0.lo developed
`risk factors only
`neither
`
`risk factors
`
`determined
`
`significant
`
`bleeding
`
`respiratory
`
`100 patients at risk
`Hastings et al
`randomly assigned
`of developiog stress ulcers and bleeding to receive antacid
`prophylaxis or no prophylaxis An analysis of the patients
`risk factors for acute GI bleeding
`reported
`failure extraabdominal
`
`renal
`
`sepsis peritonitis jaundice
`failure and hypotension Notably the frequency of bleeding
`increased with the number of risk factors
`in both
`groups Fig
`study demonstrated that
`there
`between
`acute GI ulceration and bleeding and presence of
`
`treated and untreated
`
`present
`Results of this
`
`is
`
`distinct association
`
`risk factors
`The predictive value of risk factors for GI bleeding was
`also validated in another study of patients with illnesses or
`conditions requiring admission to an ICU
`In this study
`included surgery bums major
`the risk factors considered
`trauma established liver or renal disease respiratory failure
`requiring mechanical ventilation
`sepsis and hypotension
`
`Prophylaxis
`
`No Prophylaxis
`
`at
`
`-o
`
`35
`
`30
`
`20
`
`10
`
`Risk
`
`Factor
`
`2Risk
`
`Factors
`
`3ioGRisk
`
`Factors
`
`The incidence of bleeding by number of risk factors in
`Fig
`patients receiving and not receiving antacid prophylaxis Asterisk
`.005
`.025 double dagger
`
`indicates
`
`Adapted from NEnglJMed 1978
`
`.01 dagger
`
`
`
`Page 4 of 11
`
`Patent Owner Ex. 2012
`Lupin v. Pozen
`IPR2015-01774
`
`

`
`Stress uLcer prophyLaxis
`
`39
`
`The
`
`authors
`
`demonstrated that
`
`the probability for
`massive GI bleeding from stress ulceration increased as the
`number of risk factors rose and as the intramucosal pH fell
`implying mucosal hypoperflision Gastrointestinal bleeding
`seen only in patients whose intramucosal pH
`was in fact
`had fallen below the lower limit of normality 7.24 Thus
`the combination of risk factors and intramucosal pH were the
`to note that
`best predictors of bleeding
`is important
`none of the risk factors discussed
`have been conclusively
`demonstrated to be the direct cause of stress ulcer
`
`It
`
`related
`
`they may be surrogate markers for severity
`bleeding rather
`of illness All of the studies described strongly suggest
`
`that
`
`identifing risk factors can provide
`valid predictive tool for
`GI bleeding that will allow clinicians to prescribe prophy
`treatment to the patients most likely to benefit
`risk factors associated with increased
`risk of stress
`
`lactic
`The
`
`ulcer
`
`related bleeding are summarized in Table
`
`Stress uLcer prophyLaxis options
`
`Prevention of stress-related bleeding is clearly the most
`effective strategy for patients at risk for SRMD in the ICU
`This can be accomplished by preventing gastric ischemia or
`
`that
`
`the
`
`acid
`
`receptor
`
`acid injuty Although high acid concentiations aic out
`contributes to SRMD controlling
`only factor
`production in at-risk patients seems to be protective against
`trials by
`metaanalysis of clinical
`bleeding episodes
`Cook et al
`reported that various prophylactic therapies
`and histamine2
`sucralfate
`incidence
`of overt or
`
`reduced
`
`the
`
`such
`as antacids
`antagonists H2RAs
`important bleeding compared to no prophylaxis
`clinically
`Thus agents that protect gastric mucosa from acid either by
`minimizing injury from produced acid or by inhibiting acid
`have
`an important
`role in the prevention of
`secretion
`bleeding due to SRMD
`
`5.1 Antacids
`
`Antacids work by directly buffering or neutralizing the
`contents of the stomach In the study already referred
`acidic
`to above Hastings et al
`found that
`
`in critically
`
`ill
`
`TabLe
`
`Risk factors for SRMD
`
`Risk factor
`
`Respiratory failure
`
`Coagulopathy
`
`Hypotension
`
`Sepsis
`
`Hepatic failure
`
`Renal
`
`failure
`
`Surgery
`
`Burns
`
`Major trauma
`
`Adapted from Gastroenterology 1983 Engi
`EngliMed 1994
`
`2981041
`
`Med
`
`1978
`
`patients
`
`the fact
`
`that
`
`or
`
`patients at risk for GI ulceration and bleeding the frequency
`reduced when antacid therapy
`of bleeding was significantly
`was titrated to keep the pH above 3.5 Results
`showed
`in the antacid group bled compared with
`12 patients 25% in the group receiving no prophylaxis
`.005 However
`these agents need to be
`hours to achieve
`acid neutral
`given every
`adequate
`their use cumbersome Moreover
`ization makes
`adminis
`tration of high doses of antacids may increase the risks of
`aspiration pneumonia and toxicity related to cation accu
`mulation particularly in patients with renal dysthnction
`
`that
`
`5.2 Sucratfate
`
`Sucralfate protects the gastric mucosa from acid by
`
`adhering to epithelial cells and forming protective barrier
`but has no acid-neutralizing activity Used in prevention of
`SRMD it has been shown
`to be more effective than no
`but no more
`in decreasing
`prophylaxis
`overt bleeding
`and H2RAs in reducing
`effective than placebo
`The interest
`in
`
`clinically
`
`important bleeding rates
`
`antacids
`
`sucralfate increased after
`
`clinical
`
`trial
`
`and metaanalysis
`incidence
`of pneumonia
`reported
`with sucralfate than with agents that suppress acid
`laige iandumized study uf 1200 ICU patients
`Howevet
`
`trend toward
`
`lower
`
`of nosocomial
`
`reported no difference in the incidence
`patients receiving intravenous raniti
`pneumonia between
`dine 50 mg every
`hours and those receiving sucralfate
`hours In the
`tube every
`suspension
`via nasogastric
`ranitidine group 114 19% of 596 patients had ventilator-
`pneumonia compared with 98 16% of 604
`associated
`patients in the sucralfate group More importantly clinically
`important GI bleeding was higher
`in the sucralfate
`group
`than in the ranitidine group 3.8% and 1.7% respectively
`.02
`
`5.3 H2-receptor bLockade
`
`H2RAs inhibit
`
`histamine-stimulated
`
`acid
`
`secretion
`
`by
`
`in
`
`blocking H2-receptor sites of the parietal cell
`highly
`selective manner
`they have little or no effect on histamine
`H2RAs
`not
`involved with gastric secretion
`receptors
`have
`been found to be significantly
`and
`antacids
`
`clinically
`
`in reducing
`sucralfate
`significant bleeding Fig
`
`better
`
`than placebo
`
`the
`
`incidence of
`
`5.3.1 Continuous infusion vs boLus injection
`Maintaining the pH between
`3.5 and 4.5 is
`surrogate
`endpoint accepted hy many and should be the minimum
`goal of prophylactic
`Effective prophylaxis
`therapy
`requires selection of not only the proper drug and dose but
`the appropriate method of administration
`continuous
`50-100 mg/h was
`
`infusion of cimetidine
`
`intravenous
`
`evaluated
`
`in
`
`double-blind
`study to
`placebo-controlled
`in preventing upper GI hemor
`determine its effectiveness
`intragastric pH 4.0 in both
`showed that
`rhage
`groups at baseline declined over
`time in the placebo group
`
`Results
`
`
`
`Page 5 of 11
`
`Patent Owner Ex. 2012
`Lupin v. Pozen
`IPR2015-01774
`
`

`
`40
`
`StoLLman D.C Metz
`
`for nosocomial pneumonia Navab and
`the results of several
`reported that
`Steingrub
`were conflicting They concluded
`intragastric volume severity of
`infection contributed to the development of pneumonia and
`As
`of pneumonia is multifactorial
`the pathogenesis
`noted earlier
`large well-controlled randomized trial
`difference in the rate of nosocomial pneumonia
`ranitidine was compared to sucralfate in critically
`
`laxis with potential
`
`that
`
`to find
`when
`
`ill patients
`
`studies
`
`that other factors such as
`
`illness bile reflux and
`
`failed
`
`Clinically Important
`l3leeding
`Odds Ratio 95% CI
`
`Number of
`Studies
`
`10
`
`10
`
`H2RA vs placebo
`
`H2RA vs antacids
`
`H2RA vs sucralfate
`
`Reduced
`
`increased
`
`risk
`
`risk
`
`10
`
`The results of metaanalysis on the efficacy of H2RAs in
`Fig
`stress ulcer prophylaxis Asterisk indicates overt bleeding accom
`panied by hemodynamic
`decrease
`in hemoglobin of
`changes or
`g/dL requiring transfusion of
`
`requiring surgery Adapted from JAMA 1996
`
`units of blood within 24 hours or
`
`but not in the cimetidine group and significantly less upper
`GI bleeding occurred in the cimetidine group
`.009
`This study clearly indicated that prophylaxis with
`infused cimetidine is
`valuable approach
`continuously
`preventing GI hemorrhage in patients with risk factors eg
`major surgery trauma bums hypotension
`sepsis or organ
`failure for stress-related mucosal bleeding
`given by continuous
`cimetidine
`intravenous
`Although
`infusion is currently the only regimen approved by the US
`Food and Drug Administration for prevention of stress-
`related mucosal bleeding various H2-receptor antagonists
`
`for
`
`infusion for this indication in
`
`lives
`
`iriultiple
`cimetidine
`
`either
`
`in bolus doses
`
`are often given by intermittent
`However
`the ability of these agents
`clinical practice
`when given intermittently to maintain the intragastric pH
`above 4.0 is questionable given their
`relatively short half-
`One study compared bolus doses and continuous
`infusions of cimetidine in the maintenance of intragastric
`pH above 4.0 in critically ill patients with at least one major
`traumas Patients
`were
`organ system failure ur
`randomized
`to receive
`up to 300 mg IV every
`hours or by continuous intra
`Most
`infUsion up to 50 mg/h
`for 24 hours
`venous
`patients 87
`receiving continuous infusions maintained
`strong 92.9
`their intragastric pH above 4.0 There was
`serum levels of cimetidine
`positive correlation between
`and intragastric pH above 4.0 Thus
`cimetidine given by
`continuous infusion proved to be effective in maintaining
`pH above 4.0 thereby potentially
`preventing stress ulcer
`ation Fig
`to note that although
`is important
`H2RAs dosed as
`continuous infusion are more effective in
`raising gastric pH than H2RAs dosed intermittently there
`are no comparative trials evaluating these dosing regimens
`outcomes One can only surmise that more
`complete acid suppression leads to enhanced GI protection
`
`It
`
`on clinical
`
`5.3.2 Risk of nosocomiat
`
`consequence
`
`pneumonia
`pH
`increased
`In regard to the association of
`for SRMD prophy
`of H2RA administration
`
`as
`
`the tendency
`short
`
`interval after
`
`for
`
`5.3.3 Limitations of H2RAs
`limitation of H2RAs is
`significant
`to occur within
`Two
`studies in healthy
`therapy
`subjects
`the H2RA ranitidine rapidly lost anti-
`839
`secretory effect after the first day of administration
`One study reported the development of
`tolerance
`despite
`The other study found
`dose escalations
`and
`on days
`infusions of
`ranitidine were
`to
`superior
`The
`
`tolerance
`
`initiation
`
`of
`
`demonstrated that
`
`relatively
`
`that
`
`continuous
`
`of treatment
`injections only on day
`intermittent
`latter observation may seem to contradict
`previously cited study comparing continuously infused and
`bolus doses of cimetidine However
`that study did not
`12-hour observation period thus
`beyond
`impact of tolerance was not detected
`Sonic H2RAs interfere with eytoehrorrie P450 metabo
`lizing enzymes
`leading to drug interactions
`potentially
`ranitidine inhibit P450
`Cimetidine and to
`lesser extent
`enzymes which may facilitate accumulation and possibly
`toxicity of coadministered drugs In addition H2RAs require
`dosing adjustments in the setting of renal dysfunction
`Another clinical concem is thrombocytopenia that may be
`induced by H2RAs but
`remains
`rare occurrence
`in the
`absence of another independent risk factor
`
`results of the
`
`extend
`
`the
`
`it
`
`5.4 Proton pump inhibitors
`
`Gastric acid is produced and regulated by mechanisms
`within
`Transport of
`the parietal cell
`by the
`KtATPase is
`proton pump
`the underlying mediator
`and
`step in the regulation of acid
`final
`secretion
`Proton pump inhibitors PPIs inactivate this enzyme and
`secretion by
`inhibition of
`inhibit
`acid
`specific
`gastric
`HKtATPase at
`the secretory surface of the parietal cell
`regardless of whether
`the
`cell
`
`stimulated by
`
`is
`
`histamine gastrin or acetylcholine
`The efficacy and utility of PPIs have been established for
`several acid-related GI disorders but they have not as yet
`been approved
`for GI bleeding associated
`as prophylaxis
`with stress ulceration Small open-label
`trials have examined
`the use of oral PPIs administered as extemporaneously
`compounded suspensions
`in patients at risk for stress ulcer
`No clinically
`bleeding was
`reported in these
`significant
`trials but drawing conclusions regarding efficacy is difficult
`because of
`limitations of
`
`several methodological
`comparator arm and the small
`studies such as the lack of
`
`these
`
`
`
`Page 6 of 11
`
`Patent Owner Ex. 2012
`Lupin v. Pozen
`IPR2015-01774
`
`

`
`Stress uLcer prophytaxis
`
`41
`
`significant
`
`monia
`
`in the
`
`40-mg capsule administered orally or nasogastrically once
`showed
`significantly more clinically
`day
`Results
`bleeding in the ranitidine group than
`.05 In addition fewer
`omeprazole group 3lo vs 6c
`nusueoiuial puce
`paticnts iceciving uincpiazulc dcvclopcd
`vs 14
`although the difference between groups
`was not significant
`It should be noted however
`that
`randomization
`despite
`more risk factors
`
`the ranitidine-treated
`
`had
`
`present
`
`8.0
`
`6.0
`
`0-
`
`4.0
`
`2.0
`
`300mg boles
`infusion
`
`37.5 mg/h
`
`300 mg hahn
`
`10
`
`12
`
`Time
`
`The
`
`effect of
`
`intermittent and
`
`continuons
`
`infusion
`
`Fig
`cimetidine on gastric p11 Asterisk
`Adapted with permission
`
`tive patient
`
`1985
`
`indicates effect on representa
`from Gostroenterology
`
`al
`
`additional
`
`number of patients In the first open-label study by Lasky et
`60 mechanically ventilated trauma patients with an
`received
`risk factor for stress ulcer development
`40 mg given twice on the first day
`omeprazole suspension
`hours apart
`followed by 20 mg/d Baseline
`approximately
`pH
`secondary outcome in this study was 3.3 for patients
`mean gastric pH increase to 6.7
`enrolled in this study with
`The
`after administration of omeprazole
`second
`prospective open-label study by Phillips et al
`ICU and to
`patients admitted to
`requiring mechanical
`
`surgical
`
`ventilation
`
`and with at
`
`included
`bum unit
`
`least
`
`one
`
`additional
`
`risk factor
`
`for stress ulcer disease Seventy-five
`40 mg
`received
`omeprazole suspension
`eligible patients
`hours later and
`second 40-mg dose
`followed by
`to
`thereafter 20 mg daily Four hours postomeprazole admin
`to 7.1 The mean pH was
`istration the gastric pH increased
`6.8 after starting therapy up from an initial mean baseline
`No bleeding was reported in
`pH of 3.5
`.001
`either of these trials but the number of patients enrolled is
`to adequately assess an outcome of such
`
`likely insufficient
`
`low incidence
`
`PPI with an H2RA
`Few clinical studies have compared
`for prophylaxis of UI bleeding in patients at risk for stress
`Levy
`ulceration
`compared omeprazole with
`
`et al
`
`ranitidine in patients with risk factors for stress ulcer
`bleeding Sixty-seven patients were randomized to receive
`32 as
`50-mg bolus followed by
`either ranitidine
`32 as
`50-mg IV infusion every
`hours or omeprazole
`
`related
`
`patients
`at baseline than the omeprazole
`.05
`The fact
`that PPIs are more
`group 2.7 vs 1.9
`potent pump inhibitors raises theoretical concems
`that
`their
`more potent acid suppression may actually confer increased
`more
`risk of ventilator-associated pneumonia which is
`frequent and serious problem than stress ulcer bleeding
`Additional
`randomized trials in stress ulcer patients have
`form only One study compared
`been published in abstract
`administered nasogastrically with
`omeprazole suspension
`infused ranitidine 150 or 200 mg/d in
`continuously
`58 patients with at least
`risk factors for stress ulcer
`related
`bleeding Omeprazole was shown to be superior to ranitidine
`and
`cost Clinically significant UI
`in efficacy
`safety
`bleeding occurred
`of patients receiving omeprazole
`.05
`33 vs 16 ofthose receiving ranitidine
`25
`compared the efficacy of
`Another
`via continuous infusion sucralfate
`150 mg/d
`every
`hours via nasogastric tube and omeprazole 40 mg IV every
`12 hours as prophylaxis for stress ulcers in 108 patients with
`one risk factor
`for stress-related UI bleeding
`Gastrointestinal bleeding occurred in l0.5 of patients in
`38 9.30o of those in the sucralfate
`the ranitidine group
`32 and none of those in the omeprazole group
`38
`These
`the superiority of
`suggest
`omeprazole for the prophylaxis of UI bleeding in high-risk
`patients but await the scrutiny of full-text publication
`Unlike H2RAs PPIs do not seem to develop
`with sustained therapy Two studies comparing omeprazole
`pH
`with ranitidine found that omeprazole maintained
`greater than 4.0 over 72-hour
`treatment periods
`In
`one of
`the dose of omeprazole required to
`the studies
`maintain this degree of acid suppression actually decreased
`by 43% from the first
`to the third day of treatment
`These results seem to be supported by those of pilot study
`by Morris
`This study included 202 critically ill patients
`at high risk for UI bleeding who were randomized to receive
`different dosing regimens of intravenous pantopra
`of
`standard
`zole administered intermittently or
`regimen of
`continuous infusion with each
`days The time to
`regimen given at least 48 hours and up to
`achieve pH 4.0 or more was 4.3 hours for the pantoprazole
`groups compared to 4.5 hours for the cimetidine group In
`time that pH
`of
`all pantoprazole groups
`the percentage
`compared with
`remained at or above 4.0 increased on day
`day Fig
`this percentage actually decreased
`in the cimetidine group despite administration of
`on day
`continuous infusions These data suggest
`dosing with intravenous pantoprazole can rapidly achieve
`
`in
`
`trial
`
`at
`
`least
`
`group
`
`studies
`
`ranitidine
`
`tolerance
`
`cimetidine administered as
`
`In contrast
`
`that
`
`intermittent
`
`
`
`Page 7 of 11
`
`Patent Owner Ex. 2012
`Lupin v. Pozen
`IPR2015-01774
`
`

`
`42
`
`Stoltman D.C Metz
`
`Day
`
`Day
`
`tJ
`
`100
`
`80
`
`60
`
`40
`
`20
`
`73
`
`69
`
`66
`
`86
`
`82
`
`77
`
`40mg
`
`q24h
`
`40mg
`
`ql2h
`
`80mg
`
`q24h
`
`80 mg
`
`qI2h
`
`80 mg
`
`qah
`
`Fig
`
`Med 2002
`
`The effect of intravenous pantoprazole and continuous infusion cimetidine on intragastric pH
`
`Cimetidine
`
`300 mgbolus
`
`50 mg/h
`
`202 Adapted from Cr11 Core
`
`and maintain
`
`pH of 4.0 or more in critically
`ill patients
`rapid on

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket